Financials in USD. Standardized financial statements.
A compact view of how RepliCel Life Sciences Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $353,445 | $353,736 | $353,735 | $353,735 | $353,735 | $353,735 | $353,735 | $167,661 | $0 | $0 |
| Revenue Growth? | -0.1% | +0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +111.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $1,471 | $0 | $0 | $0 | $0 | $0 | $4,155 | $5,780 |
| Gross Profit? | $0 | $353,736 | $352,264 | $353,735 | $353,735 | $353,735 | $353,735 | $121,114 | -$4,155 | -$5,780 |
| Gross Margin? | 0.0% | +100.0% | +99.6% | +100.0% | +100.0% | +100.0% | +100.0% | +72.2% | 0.0% | 0.0% |
| Operating Expenses? | $115,604 | $713,822 | $1.74M | $1.75M | $2.65M | $1.68M | $3.28M | $2.86M | $5.99M | $4.29M |
| Operating Income? | $237,840 | -$360,000 | -$1.39M | -$1.39M | -$2.30M | -$1.33M | -$2.93M | -$2.70M | -$5.99M | -$4.29M |
| EBITDA? | $237,840 | -$359,459 | -$1.39M | -$736,000 | -$4.07M | -$1.58M | -$3.00M | -$2.69M | $0 | $0 |
| Income Before Tax | -$247,028 | -$97,291 | -$312,000 | -$743,000 | -$4.07M | -$1.58M | -$3.00M | -$2.78M | -$6.01M | -$4.27M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $44,029 | $0 | $22,415 | -$16,334 |
| Net Income? | -$401,629 | -$97,291 | -$312,000 | -$743,000 | -$4.07M | -$1.58M | -$3.00M | -$2.78M | -$6.01M | -$4.27M |
| EPS? | $-0.01 | $-0.00 | $-0.01 | $-0.02 | $-0.13 | $-0.06 | $-0.13 | $-0.13 | $-0.32 | $-0.54 |
| Diluted EPS? | $-0.01 | $-0.00 | $-0.01 | $-0.02 | $-0.13 | $-0.06 | $-0.13 | $-0.13 | $-0.32 | $-0.54 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality